Available IPD datapackage for study 'An Open Label, Multicentre, Single Arm Trial to Assess the Safety of Afatinib for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)'
收藏DataCite Commons2026-02-14 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00005295.0
下载链接
链接失效反馈官方服务：
资源简介：
Primary objective of the trial is to evaluate the safety of afatinib in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR (Epidermal growth factor receptor) mutation(s) and have never been treated with an EGFR-TKI (tyrosine kinase inhibitor). Secondary objective is to assess the time to symptomatic progression (as judged by investigator).
提供机构：
Vivli
创建时间：
2026-02-14
